Pharmacovigilance of anti-cancer medicines: opportunities and challenges-Reference-Cited by-同舟云学术

Pharmacovigilance of anti-cancer medicines: opportunities and challenges

Published:2020-06-18 Issue:7 Volume:19 Page:849-860
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Crestan Diana¹^ORCID,Trojniak Marta Paulina²,Francescon Sara¹³^ORCID,Fornasier Giulia²^ORCID,Baldo Paolo¹^ORCID

Affiliation:

1. Pharmacy Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy

2. Hospital Pharmacy Unit, Institute for Maternal and Child Health “IRCCS Burlo Garofolo”, Trieste, Italy

3. Department of Hospital Pharmacy, Azienda Sanitaria Universitaria Friuli Centrale, ASUFC, Udine, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1772751

Reference97 articles.

1. WHO. Pharmacovigilance [Internet]. WHO; [cited 2020 Jan 20]. Available from: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/

2. Safety of Medicines. A guide to detecting and reporting adverse drug reactions - why health professionals need to take action: glossary [Internet]. [cited 2020 Mar 2]. Available from: https://apps.who.int/medicinedocs/en/d/Jh2992e/2.html

3. Common Terminology Criteria for Adverse Events (CTCAE). Protocol development | CTEP [Internet]. [cited 2020 Jan 20]. Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm

4. MedDRA. [Internet]. [cited 2020 Jan 20]. Available from: https://www.meddra.org/

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data;Journal of Diabetes Investigation;2024-06-29

2. Pharmacovigilance Practices by Healthcare Providers in Oncology: A Cross-Sectional Study;Pharmaceuticals;2024-05-26

3. Marine zoobenthos recognition algorithm based on improved lightweight YOLOv5;Ecological Informatics;2024-05

4. Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance;Biomedicines;2024-04-25

5. Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance;Pharmaceuticals;2024-01-12